A MHC class I & II deficient platform humanized with PBMCs
29 May 2022In this white paper, The Jackson Laboratory describes how JAX NSG-MHC I/II KO mice readily engraft tumors and human PBMCs, have delayed GvHD, and deliver translationally-relevant results for various research applications.
Related Products
Request Quote for All Products
JAX® Mice and Services
The Jackson LaboratoryTake advantage of our large inventories of common inbred strains and the convenience of having your breeding and drug efficacy needs met by the leading experts in mouse modeling.